Pear Therapeutics- Warrants (01/12/2026) Common Stock

As of the most recent data (December 2022), PEARW shows a common stock of $14K. That compares with $14K in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PEARW's common stock is now $14K (was $14K) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics- Warrants (01/12/2026) is outperforming or lagging.

Tracking PEARW's common stock over time shows whether Pear Therapeutics- Warrants (01/12/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $14K That compares with $14K in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Pear Therapeutics- Warrants (01/12/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $14K) with ownership activity and broader fundamentals.